Scientist Home Future Health Ltd (SHFH) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Scientist Home Future Health Ltd (SHFH) stock forecast summary
Our AI ranks Scientist Home Future Health Ltd outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Scientist Home Future Health Ltd is a small-cap company with a market capitalization of $40M. It ranks number 10 by market capitalization among the 16 Perfumes, Cosmetics & Other Toilet Preparations issuers in our coverage with a current forecast. Its Current Ratio of 0.37x is the lowest of the 16 peers that report one.
A per-ticker accuracy statistic for SHFH is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, SHFH included.
Follow SHFH freeSHFH price chart and AI forecast
How SHFH ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Scientist Home Future Health Ltd (SHFH) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Perfumes, Cosmetics & Other Toilet Preparations peers listed below that report each metric.
Valuation & Market
| Metric | SHFH | Rank |
|---|---|---|
| Market Cap | $40M | 10/16 |
| EPS | $-0.01 | – |
| Revenue/Share | $0.02 | – |
Profitability & Margins
| Metric | SHFH | Rank |
|---|---|---|
| ROA | -75.6% | 15/16 |
| Gross Margin | 34.1% | 11/14 |
| Operating Margin | -99.9% | 14/15 |
| Net Margin | -99.9% | 14/15 |
| EBT Margin | -99.9% | 14/15 |
| Tax Rate | -0.5% | – |
Financial Health
| Metric | SHFH | Rank |
|---|---|---|
| Current Ratio | 0.37x | 16/16 |
| Quick Ratio | 0.27x | 16/16 |
| Working Capital | -$210K | 15/16 |
Cash Flow
| Metric | SHFH | Rank |
|---|---|---|
| Operating Cash Flow | -$320K | 12/17 |
Operational Efficiency
| Metric | SHFH | Rank |
|---|---|---|
| Asset Turnover | 0.76x | 8/14 |
| Inventory Turnover | -1.2x | 13/13 |
| Fixed Assets Turnover | 6.2x | 10/13 |
| Days Inventory | -294 days | 13/13 |
| Payables Period | -329 days | 12/12 |
Income Statement
| Metric | SHFH | Rank |
|---|---|---|
| Total Revenue | $0.00M | 14/14 |
| Operating Income | $0.00M | 8/16 |
| Net Income | $0.00M | 8/16 |
| SG&A Expense | $540K | 11/12 |
| Cost of Goods Sold | -$40K | 15/15 |
Dividend & Shareholder Information
| Metric | SHFH | Rank |
|---|---|---|
| Shares Outstanding | 24M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $130K | |
| Cash & Short-term Investments | $10K | |
| Inventory | $30K | |
| Total Liabilities | $620K | |
| Short-term Debt | $300K |
SHFH quarterly financials and insider trading
Scientist Home Future Health Ltd (SHFH) industry peers
Companies classified under the same SEC industry code as Scientist Home Future Health Ltd (Perfumes, Cosmetics & Other Toilet Preparations): 19 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| SHFH Scientist Home Future Health Ltd | ▼ | $40M |
| CL Colgate Palmolive Co | ▼ | $71.71B |
| EL Estee Lauder Companies Inc | ▼ | $36.08B |
| KVUE Kenvue Inc. | ▶ | $34.11B |
| ELF E.L.F. Beauty, Inc. | ▼ | $6.38B |
| IPAR Interparfums Inc | ▼ | $3.65B |
| COTY Coty Inc. | ▲ | $2.60B |
| EPC Edgewell Personal Care Co | ▼ | $1.31B |
| WALD Waldencast Plc | ▲ | $86M |
| SLSN Solesence, Inc. | ▲ | $71M |
| AXIL Axil Brands, Inc. | ▶ | $39M |
| UG United Guardian Inc | ▲ | $32M |
| DQWS Dswiss Inc | ▶ | $17M |
| CABR Caring Brands, Inc. | ▲ | $13M |
| BNKK Bonk, Inc. | ▶ | $11M |
| YCBD Cbdmd, Inc. | ▲ | $4M |
| HLN Haleon Plc | ▼ | N/A |
| KARX Karbon-X Corp. | ▼ | N/A |
| ODD Oddity Tech Ltd | ▶ | N/A |
Where SHFH sits on the market map
Scientist Home Future Health Ltd (SHFH) stock news
Loading...
Scientist Home Future Health Ltd (SHFH) stock forecast FAQ
What is the Scientist Home Future Health Ltd (SHFH) stock forecast?
Our AI ranks Scientist Home Future Health Ltd outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Scientist Home Future Health Ltd stock predictions?
A per-ticker accuracy statistic for SHFH is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Scientist Home Future Health Ltd forecasts updated?
Scientist Home Future Health Ltd forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Scientist Home Future Health Ltd's industry peers?
19 issuers in our coverage, SHFH included, share the SEC industry code Perfumes, Cosmetics & Other Toilet Preparations. The largest are: Colgate Palmolive Co (CL), Estee Lauder Companies Inc (EL), Kenvue Inc. (KVUE), E.L.F. Beauty, Inc. (ELF), Interparfums Inc (IPAR), Coty Inc. (COTY).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.